Cambridge Investment Research Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,930
| Closed | -$152K | – | 3429 |
|
|
2024
Q1 | $152K | Buy |
10,930
+353
| +3% | +$4.91K | ﹤0.01% | 3089 |
|
|
2023
Q4 | $151K | Sell |
10,577
-5,856
| -36% | -$83.6K | ﹤0.01% | 2967 |
|
|
2023
Q3 | $254K | Buy |
16,433
+883
| +6% | +$13.6K | ﹤0.01% | 2629 |
|
|
2023
Q2 | $244K | Sell |
15,550
-335
| -2% | -$5.26K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $262K | Buy |
15,885
+233
| +1% | +$3.84K | ﹤0.01% | 2601 |
|
|
2022
Q4 | $244K | Buy |
15,652
+637
| +4% | +$9.93K | ﹤0.01% | 2595 |
|
|
2022
Q3 | $195K | Sell |
15,015
-570
| -4% | -$7.4K | ﹤0.01% | 2706 |
|
|
2022
Q2 | $219K | Buy |
15,585
+1,609
| +12% | +$22.6K | ﹤0.01% | 2656 |
|
|
2022
Q1 | $200K | Sell |
13,976
-3,397
| -20% | -$48.6K | ﹤0.01% | 2877 |
|
|
2021
Q4 | $237K | Sell |
17,373
-1,892
| -10% | -$25.8K | ﹤0.01% | 2734 |
|
|
2021
Q3 | $316K | Sell |
19,265
-1,799
| -9% | -$29.5K | ﹤0.01% | 2418 |
|
|
2021
Q2 | $355K | Buy |
21,064
+500
| +2% | +$8.43K | ﹤0.01% | 2346 |
|
|
2021
Q1 | $375K | Buy |
20,564
+8,317
| +68% | +$152K | ﹤0.01% | 2124 |
|
|
2020
Q4 | $223K | Sell |
12,247
-731
| -6% | -$13.3K | ﹤0.01% | 2392 |
|
|
2020
Q3 | $232K | Buy |
12,978
+1,609
| +14% | +$28.8K | ﹤0.01% | 2137 |
|
|
2020
Q2 | $204K | Buy |
+11,369
| New | +$204K | ﹤0.01% | 2161 |
|
|
2019
Q2 | – | Sell |
-10,352
| Closed | -$211K | – | 2343 |
|
|
2019
Q1 | $211K | Buy |
+10,352
| New | +$211K | ﹤0.01% | 2036 |
|